Abstract Views :216 |
PDF Views:0
Authors
Affiliations
1 J.N. Medical College, Sawangi (M), Wardha (Maharashtra), IN
Source
Research Journal of Pharmacology and Pharmacodynamics, Vol 7, No 1 (2015), Pagination: 19-22
Abstract
Objective: To assess prescribing trends of Fixed dose combination antidiabetics in Diabetes Mellitus patients.
Materials and Methods: An observational, cross-sectional study was carried out in the Medicine OPD of AVBRH, Sawangi(M), Wardha. A total of 500 Diabetes Mellitus Patients were selected for the study after fulfilling the inclusion/exclusion criteria.
Results: Out of 500 patients 484 patients were of type-II DM in whom 5 FDCs were prescribed. Maximum prescribed FDCs were of Metformin and sulfonylurea Metformin + Glimepiride (n=74) and Metformin + Glipizide (n=37). Following FDCs were Metformin + Voglibose (n=52), Glimepiride + Pioglitazone (n=18) and least prescribed was Metformin+ Glimepiride + Voglibose (n=10). All the drugs were prescribed by brand names. Total of 191 patients (39.46%) were prescribed Antidiabetic FDCs.
Conclusion: All Antidiabetic FDCs prescribed were rational. FDCs in Antidiabetics are useful in combination therapy for increasing patient compliance and achieving euglycemia more effectively.
Keywords
Prescribing Trends, Diabetes Mellitus, Fixed Dose Combinations.
